Clinical Trials Browser

Disease Progression × Gastrointestinal × 1 year × Clear all

Carcinoma, Hepatocellular, Stomach Neoplasms, Disease Progression

NCT07529626 2026-04-14

MIND-PANC

Not yet recruiting

320 enrolled

Gastrointestinal

Pancreatic cancer, adult, Anxiety Disorders, Depression, Pancreatic Neoplasms, Disease Progression

NCT07514455 2026-04-07

RECOMEND

Phase 2 Not yet recruiting

20 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Disease Progression

NCT04678648 2026-03-18

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Phase 1 Recruiting

134 enrolled

CNSGastrointestinalThoracic

Colonic Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Disease Progression

NCT07049055 2026-02-27

Carolyn-USA

Phase 1/2 Recruiting

144 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Disease Progression

NCT04017650 2025-11-20

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Phase 1/2 Active not recruiting

38 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Disease Progression

NCT04525833 2025-09-19

Liver Disease and Other Systemic Diseases

Recruiting

15,000 enrolled

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Diseases, Disease Progression, Carcinogenesis, Non-alcoholic Fatty Liver Disease

NCT07109024 2025-08-19

PATHFINDERS

Not yet recruiting

40 enrolled

GastrointestinalSarcoma

Disease Progression, Gastrointestinal Stromal Tumors

NCT05712356 2025-06-06

BOLSTER

Phase 2 Active not recruiting

67 enrolled

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

NCT04503265 2025-05-01

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Phase 1/2 Recruiting

122 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Disease Progression

Clinical Trials

TATE-PD1

MIND-PANC

RECOMEND

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Carolyn-USA

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Liver Disease and Other Systemic Diseases

PATHFINDERS

BOLSTER

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies